Boundless Bio, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
BOLD Nasdaq 2830 boundlessbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Boundless Bio, Inc.

Boundless Bio Announces Pipeline and Leadership Updates - Dec 12th, 2024 9:01 pm
Boundless Bio to Participate in the Piper Sandler Healthcare Conference - Nov 25th, 2024 12:00 pm
Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights - Nov 7th, 2024 9:01 pm
Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference - Nov 5th, 2024 12:00 pm
Boundless Bio Announces Departure of Chief Financial Officer - Oct 14th, 2024 12:00 pm
Is Boundless Bio (NASDAQ:BOLD) In A Good Position To Invest In Growth? - Sep 27th, 2024 12:52 pm
Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference - Sep 11th, 2024 11:00 am
Boundless Bio, Inc. (BOLD): Why Should You Buy This New Penny Stock Now? - Aug 13th, 2024 7:32 am
Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results - Aug 12th, 2024 8:01 pm
Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - Jun 5th, 2024 11:00 am
Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights - May 13th, 2024 11:00 am
Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024 - May 6th, 2024 12:00 pm
Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications - Apr 11th, 2024 12:00 pm
Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024 - Apr 8th, 2024 12:00 pm
Boundless Bio Announces Pricing of Initial Public Offering - Mar 27th, 2024 10:55 pm